Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Schizophrenia Bulletin
|
July 23, 2008
Negative symptoms in schizophrenia: avolition and Occam's razor
George Foussias, Gary Remington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
April 8, 2010
Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making
George Foussias, Gary Remington
Expert Review of Neurotherapeutics
|
April 8, 2011
Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment
Gary Remington, Ofer Agid, George Foussias
Expert Opinion on Pharmacotherapy
|
July 1, 2010
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
Ofer Agid, George Foussias, Gary Remington
CNS Drugs
|
December 25, 2009
Progress in defining optimal treatment outcome in schizophrenia
Gary Remington, George Foussias, Ofer Agid
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 23, 2010
Where to position clozapine: re-examining the evidence
Ofer Agid, George Foussias, Shayna Singh, et al.
Psychiatry Research
|
August 6, 2013
Amotivation and functional outcomes in early schizophrenia
Gagan Fervaha, George Foussias, Ofer Agid, et al.
Schizophrenia Research
|
December 17, 2013
Effect of intrinsic motivation on cognitive performance in schizophrenia: a pilot study
Gagan Fervaha, Ofer Agid, George Foussias, et al.
Schizophrenia Research
|
May 19, 2015
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome
Gagan Fervaha, George Foussias, Ofer Agid, et al.
Neuroscience and Biobehavioral Reviews
|
September 17, 2013
Neural substrates underlying effort computation in schizophrenia
Gagan Fervaha, George Foussias, Ofer Agid, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Schizophrenia Bulletin
|
July 23, 2008
Negative symptoms in schizophrenia: avolition and Occam's razor
George Foussias, Gary Remington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
April 8, 2010
Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making
George Foussias, Gary Remington
Expert Review of Neurotherapeutics
|
April 8, 2011
Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment
Gary Remington, Ofer Agid, George Foussias
Expert Opinion on Pharmacotherapy
|
July 1, 2010
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
Ofer Agid, George Foussias, Gary Remington
CNS Drugs
|
December 25, 2009
Progress in defining optimal treatment outcome in schizophrenia
Gary Remington, George Foussias, Ofer Agid
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 23, 2010
Where to position clozapine: re-examining the evidence
Ofer Agid, George Foussias, Shayna Singh, et al.
Psychiatry Research
|
August 6, 2013
Amotivation and functional outcomes in early schizophrenia
Gagan Fervaha, George Foussias, Ofer Agid, et al.
Schizophrenia Research
|
December 17, 2013
Effect of intrinsic motivation on cognitive performance in schizophrenia: a pilot study
Gagan Fervaha, Ofer Agid, George Foussias, et al.
Schizophrenia Research
|
May 19, 2015
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome
Gagan Fervaha, George Foussias, Ofer Agid, et al.
Neuroscience and Biobehavioral Reviews
|
September 17, 2013
Neural substrates underlying effort computation in schizophrenia
Gagan Fervaha, George Foussias, Ofer Agid, et al.
Page
of 14